期刊文献+

187份抗菌药物说明书对特殊人群用药说明的分析 被引量:6

Instruction for drug use for special population:analysis of 187 package inserts of antibiotics
暂未订购
导出
摘要 目的了解抗菌药物药品说明书中关于儿童、孕妇及哺乳期妇女、老年人用药项的情况,为规范药品说明书提供参考。方法收集某三级医院正在使用的抗菌药物说明书187份,对儿童用药、孕妇及哺乳期妇女用药、老年患者用药项进行调查。结果孕妇及哺乳期妇女用药较好地标注了禁忌,儿童用药的用法用量标注较详细,老年用药标注缺失较多。结论建议国家相关部门加强对药品说明书的安全监管,制定和完善药品说明书的标准格式,重视特殊人群的用药情况说明。 Objective To investigate the instruction for drug use for pediatric patients,pregnant and lactating women,and geriatric patients and to provide reference for standardizing drug package inserts.Methods A total of 187 package inserts of antibiotics collected in our hospital were analyzed for pediatric patients,pregnant and lactating women,and geriatric patients,respectively.Results In all the 187 drug package inserts,better labeling for pregnant and lactating women as to contraindications was found,labeling for pediatric patients as to dosage and administration was detailed,but labeling for geriatric patients was poor.Conclusion It is highly recommended that relevant departments in China strengthen the instruction on the safety of drug package inserts,set and improve the standard format of drug package inserts,to pay attention to the drug use of special population.
出处 《中南药学》 CAS 2009年第12期954-956,共3页 Central South Pharmacy
关键词 抗菌药物 说明书 特殊人群 antibiotics drug package insert special population
  • 相关文献

参考文献5

二级参考文献11

  • 1陈亮,孙晋海.全国城市儿童青少年生长发育趋势的研究[J].广州体育学院学报,2006,26(3):111-115. 被引量:18
  • 2成名战.谈药品包装及说明书不规范现象.时珍国医国药,2001,12(3):237-237.
  • 3The Food and Drug Administration. Milestones in U.S. Food and Drug Law, History[EB/OL] . http://www. fda. gov/cder/whatsnew. htm. 2005. 2006 - 12 - 26.
  • 4The Food and Drug Administration. Center for drug evaluation and research. NDAs: Foreign Language Labeling [ EB/OL ] . http ://www. fda. gov/cder/mapp. pdf. 2004. 2006- 12 - 26.
  • 5The Food and Drug Administration. The History of Drug Regulation in the United States [EB/OL] .http:// www. fda. gov/cder/whatsnew. htm. 2006. 2007 - 1 - 22.
  • 6Department of health and human services U.S Food and drug administration.Section 201.57.Specific requirements on content and format of labeling for human prescription drug and biological products.Part 201 labeling Title21 code of Federal Regulations USA[EB/OL].http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=201.57.2006,2007-2-9.
  • 7Department of health and human services U.S Food and drug administration.Section 201.66:Format and content requirements for over-the-counter(OTC)drug product labeling.Part 201 labeling Title 21 Code of Federal Regulations USA[EB/OL].http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSSearch.cfm?fr=201.66.2006.2007-2-18.
  • 8the Food and Drug Administration.FD & C Act Chapter Ⅶ,Subchapter F[EB/OL].http://www.fda.gov/opacom/laws/fdcact/fdctoc.html.2003,2007-3-4.
  • 9The Food and Drug Administration.FDA announces new prescription drug information format to improve patient safety[EB/OL].http://www.fda.gov/bbs/tppics/2005/NEW01272.html.2006.2007-3-22.
  • 10张杰.FDA关于处方药使用说明书的要求(译文)[J].中国临床药理学杂志,1999,15(5):394-400. 被引量:5

共引文献47

同被引文献53

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部